This special issue of Bone Marrow Transplantation describes the impact of pre-transplant molecular measurable residual disease (MRD) on acute myeloid leukemia (AML) prognosis. The original pre-MEASURE study demonstrated the superior ability of error-corrected next generation sequencing (NGS), performed retrospectively on peripheral blood pre-transplant samples in a centralized setting, to predict post-transplant relapse and survival compared to flow cytometry in patients with FLT3-ITD or NPM1 mutated AML. The current collection of manuscripts presents additional original data describing the significance of FLT3-TKD, IDH1, and IDH2 persistence prior to transplantation. Review articles cover how pre-MEASURE has impacted clinical decision-making and the interpretation of NPM1 MRD throughout the treatment course of AML. Other manuscripts address the limitations of flow cytometric MRD assays in informing conditioning regimens, the role of the Center for International Blood and Marrow Transplant Research (CIBMTR) in precision transplantation investigation, and the importance of representation in clinical research. The ongoing, prospective multicenter MEASURE study will hopefully inform the most appropriate use of peri-transplant molecular MRD for AML.

In this collection we highlight a selection of articles from 2024, which top the list of the journal’s most cited, downloaded and most shared (including press coverage, blogs, Twitter, Facebook and Weibo). The articles showcase the breadth of scope and coverage that the journal consistently delivers to its readers.

In this collection we highlight a selection of articles from 2023, which top the list of the journal’s most cited, downloaded and most shared (including press coverage, blogs, Twitter, Facebook and Weibo). The articles showcase the breadth of scope and coverage that the journal consistently delivers to its readers.

Given the increasing importance of cellular therapies in the field of hematology, this collection showcases important papers - some published in BMT but also in other journals - with a short summary of the findings and a link to the original paper for those interested. The goal is to serve the community by collating papers of interest in this key area.

This Emerging Leaders collection welcomes and recognizes new talent in the hematology field. The collection acknowledges groundbreaking researchers, clinicians, and educators who are still in the early stages of their scientific careers, serving as a platform to showcase their work.

In this collection we highlight a selection of articles from 2022, which top the list of the journal’s most cited, downloaded and most shared (including press coverage, blogs, Twitter, Facebook and Weibo). The articles showcase the breadth of scope and coverage that the journal consistently delivers to its readers.

See what readers worldwide have been citing and sharing. In this Web Focus we highlight a selection of articles from 2021, which top the list of the journal’s most cited, downloaded and most shared (including press coverage, blogs, Twitter, Facebook and Weibo). They showcase the breadth of scope and coverage that the journal consistently delivers to its readers.

This collection brings together the latest research and insight on the challenges and impact COVID-19 has had on hematopoietic cell transplantation.

In this collection we present a series of articles on topics in statistics and epidemiology, with the objective being to raise awareness of some of the complexities in design and interpretation of data from clinical trials.

See what scientists world-wide have been citing and sharing. In this Web Focus we highlight a selection of articles from 2020, which top the list of the journal’s most cited, downloaded and most shared (including press coverage, blogs, Twitter, Facebook and Weibo). They showcase the breadth of scope and coverage that the journal consistently delivers to its readers.

A collection of obituaries for key names in the field of hematology who have sadly passed, co-authored by Leukemia Editor-in-Chief, Robert Peter Gale.